- Home
- TSHA vs AOD Comparison
TSHA vs AOD Comparison
Compare TSHA & AOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TSHA | AOD |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 998.4M |
| IPO Year | 2020 | 2006 |
Fundamental Metrics
Financial Performance| Metric | TSHA | AOD |
|---|---|---|
| Price | $4.60 | $9.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $11.11 | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 571.7K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,773,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,228.40 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.28 | N/A |
| 52 Week Low | $1.13 | $7.76 |
| 52 Week High | $6.02 | $10.77 |
Technical Indicators
Market Signals| Indicator | TSHA | AOD |
|---|---|---|
| Relative Strength Index (RSI) | 51.92 | 53.51 |
| Support Level | $4.33 | $9.69 |
| Resistance Level | $4.72 | $10.10 |
| Average True Range (ATR) | 0.28 | 0.22 |
| MACD | 0.04 | 0.06 |
| Stochastic Oscillator | 70.00 | 96.05 |
Price Performance
Historical ComparisonAbout TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest
Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.